Pulmonary embolism in children with mycoplasma pneumonia: can it be predicted?
- PMID: 39688754
- DOI: 10.1007/s10096-024-05014-3
Pulmonary embolism in children with mycoplasma pneumonia: can it be predicted?
Abstract
Purpose: To investigate the clinical characteristics of Mycoplasma pneumoniae (MP) pneumonia (MPP) combined with pulmonary embolism (PE) in children.
Methods: 291 hospitalized pediatric cases with MPP were enrolled from January 2018 to May 2024 and divided into the PE group (141 cases) and non-PE control group (150 cases). Clinical data of both groups were analyzed and compared.
Results: C-reactive protein (CRP), D-dimer, lactate dehydrogenase (LDH), and interleukin 6 (IL-6) were significantly higher in the PE group than in the non-PE control group. There were 85 males and 56 females in the PE group. The PE group has male-to-female ratio of 3: 2,and hemoptysis was observed in 11 children (7.08%), chest pain in 29 children (20.60%), and pulmonary necrosis in 89 children (63.12%). In the receiver operator curve(ROC), the areas under the curve(AUC) for D-dimer, CRP, IL-6, and LDH were 0.964, 0.690, 0.632, and 0.765, respectively. In the ROC curve, the cutoff values for D-dimer, CRP, IL-6, and LDH were 0.8 µg/ml, 24.2 mg/L, 37.8 pg/ml, and 461 U/L, respectively.
Conclusion: A proportion of children with MP infection combined with PE show atypical clinical symptoms. Children with MPP and elevated D-dimer levels, IL-6, CRP, erythrocyte sedimentation rate (ESR), and LDH may be prone to develop PE.
Keywords: Mycoplasma pneumoniae pneumonia; C-reactive protein; D-dimer; Interleukin 6; Lactate dehydrogenase; Pulmonary embolism.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This study was approved by the Ethics Committee of Henan Children’s Hospital (2022-K-L046) (retrospectively registration). Due to the retrospective nature of the study, Institutional Review Board waived the need of obtaining informed consent. This research adheres to the ethical standards of the Declaration of Helsinki. Consent to participate: The data used in this study have been obtained with the consent of the person concerned. Informed consent was obtained from all individual participants included in the study. Consent for publication: The authors confirmed that human study participants provided informed consent for the release of the images in Figs. 1 and 2; Tables 1 and 2, and 3. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.BMC Infect Dis. 2020 Jul 22;20(1):534. doi: 10.1186/s12879-020-05270-6. BMC Infect Dis. 2020. PMID: 32698769 Free PMC article.
-
Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.BMC Infect Dis. 2021 Jan 6;21(1):14. doi: 10.1186/s12879-020-05700-5. BMC Infect Dis. 2021. PMID: 33407216 Free PMC article.
-
Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia.BMC Infect Dis. 2021 Jan 13;21(1):67. doi: 10.1186/s12879-021-05765-w. BMC Infect Dis. 2021. PMID: 33441105 Free PMC article.
-
Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors.J Immunol Res. 2022 Jun 26;2022:9227838. doi: 10.1155/2022/9227838. eCollection 2022. J Immunol Res. 2022. PMID: 35795531 Free PMC article.
-
Pulmonary thromboembolism due to Mycoplasma pneumoniae in children: a case report and literature review.BMC Pediatr. 2024 Dec 19;24(1):816. doi: 10.1186/s12887-024-05283-z. BMC Pediatr. 2024. PMID: 39696161 Free PMC article. Review.
References
-
- LIU B M, BECK E M, FISHER MA (2021) The brief case: Ventilator-Associated Corynebacterium accolens Pneumonia in a patient with respiratory failure due to COVID-19 [J]. J Clin Microbiol 59(9):e0013721. https://doi.org/10.1128/jcm.00137-21 - DOI
-
- TORRES A, CILLONIZ C (2021) Pneumonia [J]. Nat Rev Dis Primers 7(1):25. https://doi.org/10.1038/s41572-021-00259-0 - DOI - PubMed
-
- YU J, QIAN S, LIU C et al (2020) Viral etiology of life-threatening pediatric pneumonia: a matched case-control study [J]. Influenza Other Respir Viruses 14(4):452–459. https://doi.org/10.1111/irv.12738 - DOI - PubMed - PMC
-
- LIU B, TOTTEN M (2020) Development and evaluation of a fully automated Molecular Assay Targeting the mitochondrial small subunit rRNA gene for the detection of Pneumocystis Jirovecii in Bronchoalveolar Lavage fluid specimens [J]. J Mol Diagn 22(12):1482–1493. https://doi.org/10.1016/j.jmoldx.2020.10.003 - DOI - PubMed
-
- XU M, LI Y, SHI Y et al (2024) Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022 [J]. BMC Microbiol 24(1):23. https://doi.org/10.1186/s12866-024-03180-0 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous